These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 224197

  • 1. Role of oral contraceptive agents in the pathogenesis of liver tumors.
    Nissen ED, Kent DR, Nissen SE.
    J Toxicol Environ Health; 1979; 5(2-3):231-54. PubMed ID: 224197
    [Abstract] [Full Text] [Related]

  • 2. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK, Schwartz SI.
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [Abstract] [Full Text] [Related]

  • 3. Hepatic tumors induced by sex steroids.
    Mays ET, Christopherson W.
    Semin Liver Dis; 1984 May; 4(2):147-57. PubMed ID: 6087460
    [Abstract] [Full Text] [Related]

  • 4. Relation of steroids to liver oncogenesis.
    Christopherson WM, Mays ET.
    J Toxicol Environ Health; 1979 May; 5(2-3):207-30. PubMed ID: 224196
    [Abstract] [Full Text] [Related]

  • 5. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
    Brouquet J, Chameaud J, Vire O, Fabre P, Catanzano G, Baudet JH.
    Rev Fr Gynecol Obstet; 1985 May; 80(8-9):621-7. PubMed ID: 2997901
    [Abstract] [Full Text] [Related]

  • 6. [Oral contraceptive-induced liver tumors and pregnancy].
    Wilhelm C, Quaas L, Zahradnik HP, Breckwoldt M.
    Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):806-9. PubMed ID: 1962751
    [Abstract] [Full Text] [Related]

  • 7. Survey of primary liver tumors and oral contraceptive use.
    Vana J, Murphy GP, Aronoff BL, Baker HW.
    J Toxicol Environ Health; 1979 Oct; 5(2-3):255-73. PubMed ID: 224198
    [Abstract] [Full Text] [Related]

  • 8. Association of liver tumors with oral contraceptives.
    Nissen ED, Kent DR, Nissen SE, McRae DM.
    Obstet Gynecol; 1976 Jul; 48(1):49-55. PubMed ID: 180466
    [Abstract] [Full Text] [Related]

  • 9. [Clinical, epidemiological, morphological and etiopathogenetic aspects of benign tumors of hepatocytic derivation, with description of a case of focal nodular hyperplasia].
    Bontempini L, Wittels M, Franceschini F.
    Arch De Vecchi Anat Patol; 1981 Dec; 64(3):547-68. PubMed ID: 6284066
    [Abstract] [Full Text] [Related]

  • 10. Liver tumors in women on contraceptive steroids.
    Christopherson WM, Mays ET, Barrows GH.
    Obstet Gynecol; 1975 Aug; 46(2):221-3. PubMed ID: 168523
    [Abstract] [Full Text] [Related]

  • 11. Liver-cell adenomas associated with use of oral contraceptives.
    Edmondson HA, Henderson B, Benton B.
    N Engl J Med; 1976 Feb 26; 294(9):470-2. PubMed ID: 173996
    [Abstract] [Full Text] [Related]

  • 12. Proper management of hepatic adenoma associated with oral contraceptives.
    Chan CK, Detmer DE.
    Surg Gynecol Obstet; 1977 May 26; 144(5):703-6. PubMed ID: 66762
    [Abstract] [Full Text] [Related]

  • 13. Focal nodular hyperplasia of the liver and hepatic cell adenoma in women on oral contraceptives.
    Bartók I, Decastello A, Csikós F, Nagy I.
    Hepatogastroenterology; 1980 Dec 26; 27(6):435-40. PubMed ID: 6259038
    [Abstract] [Full Text] [Related]

  • 14. [Focal nodular hyperplasia and hepatocytic adenoma in the liver of women taking contraceptive tablets].
    Bartók I, Decastella A, Csikós F, Nagy I.
    Orv Hetil; 1979 Oct 21; 120(42):2541-4. PubMed ID: 231246
    [No Abstract] [Full Text] [Related]

  • 15. [Management of liver cell adenoma and focal nodular hyperplasia].
    Akovbiantz A, Ackermann D, Bühler H, Schmid M.
    Helv Chir Acta; 1980 Dec 21; 47(5):607-9. PubMed ID: 6259090
    [Abstract] [Full Text] [Related]

  • 16. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
    Herman P, Machado MA, Volpe P, Pugliese V, Vianna MR, Bacchella T, Machado MC, Pinotti HW.
    Rev Hosp Clin Fac Med Sao Paulo; 1994 Dec 21; 49(1):30-3. PubMed ID: 8029613
    [Abstract] [Full Text] [Related]

  • 17. Oral contraceptives and cancer of the liver: a review with two additional cases.
    Helling TS, Wood WG.
    Am J Gastroenterol; 1982 Jul 21; 77(7):504-8. PubMed ID: 6283882
    [Abstract] [Full Text] [Related]

  • 18. [Hepatic and biliary repercussions of estrogens: dose or duration of treatment effect].
    Hecht Y.
    Contracept Fertil Sex (Paris); 1991 May 21; 19(5):403-8. PubMed ID: 12316961
    [Abstract] [Full Text] [Related]

  • 19. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases.
    Imkie M, Myers SA, Li Y, Fan F, Bennett TL, Forster J, Tawfik O.
    J Reprod Med; 2005 Aug 21; 50(8):633-7. PubMed ID: 16220774
    [Abstract] [Full Text] [Related]

  • 20. Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.
    Tajada M, Nerín J, Ruiz MM, Sánchez-Dehesa M, Fabre E.
    Eur J Contracept Reprod Health Care; 2001 Dec 21; 6(4):227-30. PubMed ID: 11848652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.